Clinical R&D

IBR Inc. serves the pharmaceutical and biotechnology industry by developing, validating, and performing sample analysis in support of clinical studies in a stringent Good Laboratory Practise (GLP) environment. Our methods are tailored to the requirements of the clinical program with a core competence in analysing biopharmaceutical drugs in complex biological matrices, immuno-profiling and immunogenicity assessment. The methods are developed for specific issues of clinical development or transferred from preclinical development and adapted to the requirements of clincal testing.

The following analytical services are in the focus:

In addition, IBR Inc. provides state of the art clinical sample management and storage. More...